BIO-TECHNE CORP (TECH) Forecast, Price Target & Analyst Ratings

NASDAQ:TECHUS09073M1045

Current stock price

51.61 USD
+0.8 (+1.57%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIO-TECHNE CORP (TECH).

Forecast Snapshot

Consensus Price Target

Price Target
$76.73
+ 48.66% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q3 / 2026
EPS Estimate
$0.55
Revenue Estimate
323.09M

ChartMill Buy Consensus

Rating
80.87%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$76.73
Upside
+ 48.66%
From current price of $51.61 to mean target of $76.73, Based on 23 analyst forecasts
Low
$65.65
Median
$76.50
High
$84.00

Price Target Revisions

1 Month
7.39%
3 Months
8.38%

Price Target Summary

23 Wall Street analysts provided a forecast for the next 12 months for TECH. The average price target is 76.73 USD. This implies a price increase of 48.66% is expected in the next year compared to the current price of 51.61.
The average price target has been revised upward by 8.38% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

TECH Current Analyst RatingTECH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

TECH Historical Analyst RatingsTECH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
80.87%
TECH was analyzed by 23 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about TECH.
In the previous month the buy percentage consensus was at a similar level.
TECH was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-06Wells FargoMaintains Overweight -> Overweight
2026-02-05TD CowenMaintains Buy -> Buy
2026-02-05UBSMaintains Buy -> Buy
2026-02-05StifelMaintains Hold -> Hold
2026-02-05Evercore ISI GroupMaintains In-Line -> In-Line
2026-02-05CitigroupMaintains Buy -> Buy
2026-01-05Evercore ISI GroupDowngrade Outperform -> In-Line
2025-11-20Argus ResearchMaintains Buy -> Buy
2025-11-06UBSMaintains Buy -> Buy
2025-11-06Wells FargoMaintains Overweight -> Overweight
2025-10-14TD CowenMaintains Buy -> Buy
2025-10-07Evercore ISI GroupMaintains Outperform -> Outperform
2025-09-03RBC CapitalUpgrade Sector Perform -> Outperform
2025-08-21CitigroupUpgrade Neutral -> Buy
2025-08-07RBC CapitalMaintains Sector Perform -> Sector Perform
2025-07-11ScotiaBankMaintains Sector Outperform -> Sector Outperform
2025-07-09TD CowenInitiate Buy
2025-06-05BenchmarkReiterate Buy -> Buy
2025-05-30Wells FargoInitiate Overweight
2025-05-09UBSMaintains Buy -> Buy
2025-05-08RBC CapitalMaintains Sector Perform -> Sector Perform
2025-05-08BenchmarkMaintains Buy -> Buy
2025-05-08StifelMaintains Hold -> Hold
2025-04-09KeybancDowngrade Overweight -> Sector Weight
2025-04-08KeybancDowngrade Overweight -> Sector Weight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q3 / 2026
EPS Estimate
$0.55
Revenue Estimate
323.09M
Revenue Q2Q
2.19%
EPS Q2Q
-2.05%
Number of Analysts
16

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-1.44%
EPS (1 Month)
-0.99%
EPS (3 Months)
-4.78%

Next Earnings Summary

TECH is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.55 USD and the consensus revenue estimate is 323.09M USD.
The next earnings revenue estimate has been revised downward by 1.44% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
TECH revenue by date.TECH revenue by date.
1.137B
2.81%
1.159B
1.97%
1.22B
5.23%
1.25B
2.49%
1.33B
6.40%
1.459B
9.70%
1.56B
6.92%
1.749B
12.12%
2.186B
24.99%
2.403B
9.93%
EBITDA
YoY % growth
TECH ebitda by date.TECH ebitda by date.
400.8M
0.38%
362.87M
-9.46%
375.265M
3.42%
447.97M
19.37%
487.34M
8.79%
538.76M
10.55%
574.26M
6.59%
579.36M
0.89%
880.67M
52.01%
988.58M
12.25%
EBIT
YoY % growth
TECH ebit by date.TECH ebit by date.
293.6M
-1.54%
251.159M
-14.46%
265.362M
5.65%
405.46M
52.80%
443.11M
9.29%
501.66M
13.21%
581.3M
15.88%
748.68M
28.79%
843.44M
12.66%
949.82M
12.61%
Operating Margin
TECH operating margin by date.TECH operating margin by date.
25.83%21.67%21.76%32.44%33.32%34.38%37.26%42.81%38.58%39.53%
EPS
YoY % growth
TECH eps by date.TECH eps by date.
2.00
1.01%
1.78
-10.78%
1.93
8.43%
2.03
5.04%
2.23
9.76%
2.57
15.73%
2.81
9.13%
2.92
3.81%
N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth
0.55
-2.05%
0.58
8.69%
0.47
12.71%
0.51
9.89%
0.63
15.50%
0.64
10.37%
0.50
5.58%
0.54
6.95%
0.68
7.87%
0.66
4.28%
Revenue
Q2Q % growth
323.09M
2.19%
333.97M
5.37%
305.49M
6.61%
318.74M
7.73%
352.69M
9.16%
358.5M
7.34%
317.07M
3.79%
327.93M
2.88%
377.45M
7.02%
375.68M
4.79%
EBITDA
Q2Q % growth
119.84M
-26.32%
125.91M
-33.07%
103.95M
32.46%
111.13M
-0.31%
137.27M
14.54%
137.72M
9.38%
103.44M
-0.49%
111.42M
0.26%
142.61M
3.89%
138.25M
0.38%
EBIT
Q2Q % growth
109.42M
37.02%
112.05M
43.25%
93.645M
72.97%
100.19M
60.48%
125.34M
14.55%
127.01M
13.35%
97.522M
4.14%
105.43M
5.23%
136.45M
8.86%
132.05M
3.97%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TECH Yearly Revenue VS EstimatesTECH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
TECH Yearly EPS VS EstimatesTECH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
10.09%
EPS Next 5 Year
8.61%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
5.54%
Revenue Next 5 Year
7.10%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
11.92%
EBIT Next 5 Year
8.56%

BIO-TECHNE CORP / TECH Forecast FAQ

What do analysts expect the price target to be for BIO-TECHNE CORP (TECH)?

23 analysts have analysed TECH and the average price target is 76.73 USD. This implies a price increase of 48.66% is expected in the next year compared to the current price of 51.61.

When does BIO-TECHNE CORP (TECH) report earnings?

BIO-TECHNE CORP (TECH) will report earnings on 2026-05-05, before the market open.

What are the consensus estimates for BIO-TECHNE CORP (TECH) next earnings?

The consensus EPS estimate for the next earnings of BIO-TECHNE CORP (TECH) is 0.55 USD and the consensus revenue estimate is 323.09M USD.

Can you provide the consensus rating for BIO-TECHNE CORP stock?

The consensus rating for BIO-TECHNE CORP (TECH) is 80.8696 / 100 . This indicates that analysts generally have a positive outlook on the stock.